Combination Group
Combination Group is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke
The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA
Pain Neuroscience Education and Motor Imagery-based Exercise Protocol for Patients With Fibromyalgia
Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment
Effectiveness of Digital Manipulation of Thyroid Cartilage and Fluency Shaping Therapy for the Management of Stuttering in Adult
Clinical Trials (8)
Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke
The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA
Pain Neuroscience Education and Motor Imagery-based Exercise Protocol for Patients With Fibromyalgia
Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment
Effectiveness of Digital Manipulation of Thyroid Cartilage and Fluency Shaping Therapy for the Management of Stuttering in Adult
Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer
Prevention of Intraoperative Nausea and Vomiting During Cesarean Section
Effects of Lutein Supplementation on Subclinical Atherosclerosis
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8